• Non-AAV, Non-rare Gene Therapy with Derek Jackson, Pacira BioSciences–The Issue

  • Oct 15 2024
  • Length: 44 mins
  • Podcast

Non-AAV, Non-rare Gene Therapy with Derek Jackson, Pacira BioSciences–The Issue

Listen for free

View show details

  • Summary

  • Derek Jackson, vice president of cell and gene therapy product development at Pacira BioSciences, joins The Issue to take the program in a different direction.

    We often focus our discussions on CGT for rare diseases. Most of the time, the teams of scientists working on the program don’t have any personal experience with the disease from their family, friends, or themselves.. but today we will talk about gene therapy development for a much more common disease: knee osteoarthritis. Moreover, the product we will be discussing is not only non-rare but also non-AAV.

    Music by: https://www.steven-obrien.net/
    --------------------------
    Bright New Morning - Steven O'Brien

    (Used for free under a Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/)

    Show your support for ASGCT!: https://asgct.org/membership/donate

    See omnystudio.com/listener for privacy information.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Non-AAV, Non-rare Gene Therapy with Derek Jackson, Pacira BioSciences–The Issue

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available